ATP11C activators comprise a category of chemical agents that facilitate the activation of ATP11C, a P4-type ATPase flippase that is essential for the maintenance of membrane asymmetry by translocating specific phospholipids from the outer to the inner leaflet of the plasma membrane. The proper function of ATP11C is crucial for various cellular processes, including vesicle formation, cell division, and apoptosis, due to its role in maintaining the lipid composition of the cell membrane.
The mechanism of action of ATP11C activators can be direct, where the chemicals bind to ATP11C and enhance its ATPase activity, thereby increasing the energy-dependent translocation of phospholipids. This enhancement could be a result of allosteric modulation where the binding of the activator changes the conformation of ATP11C to a more active state. Direct activators might also interact with the protein's catalytic or lipid-binding sites, leading to an increase in substrate affinity or catalytic turnover rate. Indirect activators, on the other hand, could increase the expression levels of ATP11C, stabilize the protein, or interact with regulatory proteins that modulate ATP11C's activity. They might also affect the local lipid environment of the protein, which is known to play a significant role in the activity of lipid translocases. Research involving ATP11C activators is deeply rooted in the exploration of cellular biochemistry and membrane dynamics. These activators are powerful tools for scientists to dissect the fundamental processes of cellular membrane maintenance and phospholipid dynamics. Through a variety of experimental approaches, including enzymatic activity assays, lipidomics, and fluorescence microscopy, researchers can observe the effects of ATP11C activation on membrane asymmetry and integrity, as well as the broader implications for cellular physiology.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ADP | 58-64-0 | sc-507362 | 5 g | $53.00 | ||
ATP is the substrate for ATP11C, which is an ATPase. More ATP in the cell can increase the function of ATP11C, as it uses ATP to fuel its activity. | ||||||
Magnesium chloride | 7786-30-3 | sc-255260C sc-255260B sc-255260 sc-255260A | 10 g 25 g 100 g 500 g | $27.00 $34.00 $47.00 $123.00 | 2 | |
Magnesium is a cofactor for ATPases. Higher intracellular magnesium levels could enhance the functional activity of ATP11C. | ||||||
Calcium chloride anhydrous | 10043-52-4 | sc-207392 sc-207392A | 100 g 500 g | $65.00 $262.00 | 1 | |
Calcium ions might increase ATP11C activity as they play a role in the regulation of ATPase functions. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $45.00 $56.00 $183.00 | 142 | |
This compound is a general inhibitor of ATPases, it could lead to a compensatory increase in ATP11C activity. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $506.00 | |||
Ouabain is an inhibitor of Na+/K+-ATPase. Inhibition of Na+/K+-ATPase can lead to changes in ion balance, which might indirectly increase ATP11C function. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $140.00 $680.00 | ||
12β-Hydroxydigitoxin is another Na+/K+-ATPase inhibitor. Similar to Ouabain, it could indirectly enhance ATP11C function by changing ion balance. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin is an adenylate cyclase activator, leading to increased cAMP levels and PKA activation. This could enhance ATP11C transcription as cAMP signaling is known to regulate gene expression. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a phosphodiesterase inhibitor that raises intracellular cAMP levels, potentially enhancing ATP11C transcription via cAMP-mediated pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Another phosphodiesterase inhibitor, Rolipram could enhance ATP11C transcription by increasing cAMP levels and PKA activation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $97.00 $224.00 | 30 | |
This cAMP analog can stimulate cAMP-dependent pathways, possibly leading to enhanced ATP11C transcription. | ||||||